APA (7th ed.) Citation

JRB, F., AC, C., E, S., LR, d. V. A., V, P., IM, d. R., . . . A, T. (2023). Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients. Clinical immunology (Orlando, Fla.), 251, 109321. https://doi.org/10.1016/j.clim.2023.109321

Chicago Style (17th ed.) Citation

JRB, Fradico, et al. "Serum Soluble Mediators as Prognostic Biomarkers for Morbidity, Disease Outcome, and Late-relapsing Hepatitis in Yellow Fever Patients." Clinical Immunology (Orlando, Fla.) 251 (2023): 109321. https://doi.org/10.1016/j.clim.2023.109321.

MLA (9th ed.) Citation

JRB, Fradico, et al. "Serum Soluble Mediators as Prognostic Biomarkers for Morbidity, Disease Outcome, and Late-relapsing Hepatitis in Yellow Fever Patients." Clinical Immunology (Orlando, Fla.), vol. 251, 2023, p. 109321, https://doi.org/10.1016/j.clim.2023.109321.